Pediatric Atopic Dermatitis Linked to Shorter Stature in TriNetX Analysis
A TriNetX cohort analysis found pediatric AD carries a 1.15 relative risk of height below the fifth percentile, while 2026 dupilumab BALP data remain hypothesis on growth effects.
